Clinical Trial

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

Study acronym: RAKGEORREC
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant schizophrenia and RECOVERYTRSBDGR for patients with treatment- resistant bipolar disorder.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-02
notable Enrollment increased: 40 -> 84 participants 2026-05-02
Trial Details
NCT Number NCT07047651
Lead Sponsor Dr. Stavroula Rakitzi
Conditions Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
Enrollment 84 participants
Start Date 2025-06-04
Primary Completion 2027-12-20 (estimated)
Study Completion 2027-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-01